Streetbeat News

Stock Prices

ALT

Altimmune (NASDAQ:ALT) is set to release its quarterly earnings report on August 10, 2023. Analysts estimate an earnings per share (EPS) of $-0.46. The company's past performance shows a pattern of beating EPS estimates but experiencing a drop in share price. Altimmune's shares are currently trading at $3.01, down 78.47% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 3:01 pm

MAXN

Maxeon Solar Technologies (NASDAQ:MAXN) is set to release its latest quarterly earnings report on August 10, 2023. Analysts estimate an earnings per share (EPS) of $-0.08. The company's past performance shows a trend of beating EPS estimates, which has often led to an increase in share price. The stock is currently trading at $23.21 and has seen a 17.79% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 3:01 pm

SCPH

scPharmaceuticals (NASDAQ:SCPH) is set to release its latest quarterly earnings report on August 10, 2023. Analysts estimate an earnings per share (EPS) of $-0.37. The company's past performance shows a pattern of beating EPS estimates, but this has sometimes been followed by a drop in share price. The stock is currently trading at $7.88 and has seen a 32.57% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 3:01 pm

BNTX

BioNTech SE (BNTX) shares are trading higher by 4.66% to $106.51 after falling on Monday. The company's Q2 revenues were €167.7 million, a decline from €3.2 billion in the previous year. The reduction is attributed to write-offs by collaboration partner Pfizer Inc, leading to a decrease in the company's gross profit share for the quarter.

Portfolio Pulse from Henry Khederian

August 09, 2023 | 3:01 pm

CBAY

CymaBay Therapeutics (NASDAQ:CBAY) is set to release its quarterly earnings report on August 10, 2023. Analysts estimate an EPS of $-0.20. The company's past performance shows a pattern of share price changes following earnings reports. The stock is currently trading at $12.4, up 234.63% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 3:01 pm

ACB

Aurora Cannabis (NASDAQ:ACB) is set to release its quarterly earnings report on August 10, 2023. Analysts estimate an earnings per share (EPS) of $-0.08. The company's past performance shows a trend of missing EPS estimates, which has led to drops in share price. Over the last 52-week period, shares are down 66.12%.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 3:01 pm

NRXS

Trading of Neuraxis shares has resumed.

Portfolio Pulse from Happy Mohamed

August 09, 2023 | 3:01 pm

MUX

McEwen Mining (NYSE:MUX) is set to release its latest quarterly earnings report on August 10, 2023. Analysts estimate an earnings per share (EPS) of $-0.74. The company's past performance shows a mix of positive and negative price changes post-earnings release. The stock is currently trading at $7.51 and has seen a 126.14% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 3:01 pm

BCO

Brinks Company reported worse-than-expected Q2 adjusted EPS results and issued FY23 guidance, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 3:01 pm

EXAI

Exscientia (NASDAQ:EXAI) is set to release its latest quarterly earnings report on August 10, 2023. Analysts estimate an earnings per share (EPS) of $-0.41. The company's past performance shows a trend of share price drops following earnings reports. The stock is currently trading at $7.55, down 35.24% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 3:01 pm